Solitary pulmonary nodules differentiated by Dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease

Journal of Radiation Research

Volumn 53, Issue 2, 2012, Pages 306-312

  Huang, Yu Erh ^a,b   Lu, Hung I ^a   Liu, Feng Yuan ^a   Huang, Yu Jie ^a   Lin, Meng Chih ^a   Chen, Chin Feng ^a   Wang, Pei Wen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

F 18 fluorodeoxyglucose; Kinetic analysis; Positron emission tomography; Solitary pulmonary nodules

Indexed keywords

TUMORS;

CLASSIFIEDS; F-18 FLUORODEOXYGLUCOSE; FDG PET; FLUORODEOXYGLUCOSE; KINETIC ANALYSIS; PET IMAGING; PULMONARY NODULES; SOLITARY PULMONARY NODULE; TIME-ACTIVITY-CURVES; VOLUME OF INTEREST;

POSITRON EMISSION TOMOGRAPHY;

EID: 84863496831     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11089     Document Type: Article

References (38)

1. Tan BB, et al (2003) The solitary pulmonary nodule. Chest 123(suppl 1): 89S-96S.
2. Gupta NC, Maloof J and Gunel E (1996) Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 37(6): 943-948.
3. Ost D, Fein AM and Feinsilver SH (2003) The solitary pulmonary nodule. N Engl J Med 348(25): 2535-2542.
4. Lowe VJ, et al (1998) Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16(3): 1075-1084.
5. Cummings SR, Lillington GA and Richard RJ (1986) Managing solitary pulmonary nodules: the choice of strategy is a close call. Am Rev respiratory dis 134(3): 453-460.
6. Jeudy J, et al (2008) Management of small (3-5-mm) pulmonary nodules at chest CT: global survey of thoracic radiologists. Radiology 247(3): 847-853.
7. Khouri NF, et al (1987) The solitary pulmonary nodule. Assessment, diagnosis, and management. Chest 91(1): 128-133.
8. Siegelman SS, et al (1986) Solitary pulmonary nodules: CT assessment. Radiology 160(2): 307-312.
9. Gupta N, et al (1992) Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-Dglucose. Radiology 184(2): 441-444.
10. Dewan NA, et al (1993) Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 104(4): 997-1002.
11. Flier JS, et al (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235(4795): 1492-1495.
12. Monakhov N, et al (1978) Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 61(1): 27-34.
13. Gould MK, et al (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. JAMA: the journal of the American Medical Association 285(7): 914-924.
14. Chang JM, et al (2006) False positive and false negative FDGPET scans in various thoracic diseases. Korean J Rad 7(1): 57-69.
15. Bryant AS and Cerfolio RJ (2006) The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. The Annals of thoracic surgery 82(3): 1016-1020.
16. Huang SC, et al (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiology- Endocrinology And Metabolism 238(1): E69-E82.
17. Torizuka T, et al (1998) Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies. Radiology 207(3): 767-774.
18. Doot RK, et al (2007) Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF. J Nucl Med 48(6): 920-925.
19. Gupta N, et al (1998) Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 114(4): 1105-1111.
20. Nitzsche EU, et al (2002) Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? Eur J Nucl Med 29(2): 237-242.
21. Patlak CS, Blasberg RG and Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple- time uptake data. J Cereb Blood Flow Metab 3(1): 1-7.
22. Hiibner KF, et al (1996) Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. Clin Nucl Med 21(12): 941-949.
23. Lodge MA, et al (1999) A PET study of 18 FDG uptake in soft tissue masses. Eur J Nucl Med Molecular Imaging 26(1): 22-30.
24. Zhao S, et al (2008) Differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and l8F-FLT. J Nucl Med 49(1): 135-141.
25. Grgic A, et al (2010) Risk stratification of solitary pulmonary nodules by means of PET using 18 F-fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Molecular Imaging 37(6): 1087-1094.
26. Hamberg LM, et al (1994) The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 35(8): 1308-1312.
27. Knight SB, et al (1996) Evaluation of pulmonary lesions With FDG-PET. Chest 109(4): 982-988.
28. Lowe VJ, et al (1997) Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 202(2): 435-439.
29. Lewis PJ and Salama A (1994) Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35(10): 1647-1649.
30. Goo JM, et al (2000) Pulmonary Tuberculoma Evaluated by Means of FDG PET: Findings in 10 Cases. Radiology 216(1): 117-121.
31. Sathekge MM, et al (2010) Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. SAMJ: South African Medical Journal 100(9): 598-601.
32. Jahun J and Sheu M (2004) TB policy and related issues in Taiwan: organizational developments and notification policy changes. Taiwan J Public Health 23: 292-296.
33. Gurney JW, Lyddon DM and McKay JA (1993) Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology 186(2): 415-422.
34. Saha G (2005) Basics of PET Imaging: Physics, Chemistry, and Regulations. USA: Springer, Science Business Media, Inc., pp. 70-71.
35. Soret M, Bacharach SL and Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48(6): 932-945.
36. Fang YHD and Muzic Jr RF (2008) Spillover and partialvolume correction for image-derived input functions for small-animal 18F-FDG PET studies. J Nucl Med 49(4): 606-614.
37. Goerres GW, et al (2002) Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 43(11): 1469-1475.
38. Erdi YE, et al (2004) The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med 45(8): 1287-1292.